Group One Trading
LPCN icon

Group One Trading’s Lipocine LPCN Stock Holding History

Group One Trading’s Portfolio LPCN Stock Details LPCN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-56,900
Closed -$157K – 7562
2023
Q4 		$157K Sell
56,900
-100
-0.2% -$265 ﹤0.01% 4075
2023
Q3 		$168K Hold
57,000
– – ﹤0.01% 3960
2023
Q2 		$285K Buy
57,000
+53,218
+1,407% +$250K ﹤0.01% 3590
2023
Q1 		$20.5K Sell
3,782
-24,777
-87% -$191K ﹤0.01% 5495
2022
Q4 		$193K Buy
28,559
+1,483
+5% +$10.8K ﹤0.01% 3893
2022
Q3 		$207K Buy
27,076
+264
+1% +$2.95K ﹤0.01% 4113
2022
Q2 		$365K Sell
26,812
-870
-3% -$13.6K ﹤0.01% 3713
2022
Q1 		$645K Sell
27,682
-4,071
-13% -$85.2K ﹤0.01% 3542
2021
Q4 		$535K Sell
31,753
-5,041
-14% -$93.6K ﹤0.01% 4062
2021
Q3 		$682K Buy
36,794
+23,729
+182% +$524K ﹤0.01% 3849
2021
Q2 		$311K Sell
13,065
-4,770
-27% -$112K ﹤0.01% 4751
2021
Q1 		$458K Buy
17,835
+2,206
+14% +$63.7K ﹤0.01% 4142
2020
Q4 		$361K Buy
15,629
+12,505
+400% +$301K ﹤0.01% 3560
2020
Q3 		$75K Buy
3,124
+1,059
+51% +$28.1K ﹤0.01% 4385
2020
Q2 		$44K Buy
+2,065
New +$26.8K ﹤0.01% 4445
2019
Q4 		– Sell
-12
Closed -$1K – 5390
2019
Q3 		$1K Sell
12
-706
-98% -$28.3K ﹤0.01% 4989
2019
Q2 		$24K Buy
718
+306
+74% +$9.44K ﹤0.01% 4100
2019
Q1 		$16K Buy
+412
New +$12.6K ﹤0.01% 4100
2018
Q4 		– Sell
-588
Closed -$14K – 5169
2018
Q3 		$14K Sell
588
-147
-20% -$3.62K ﹤0.01% 4537
2018
Q2 		$16K Buy
735
+400
+119% +$9.54K ﹤0.01% 4455
2018
Q1 		$9K Sell
335
-4,130
-92% -$115K ﹤0.01% 4350
2017
Q4 		$261K Buy
4,465
+400
+10% +$24.9K ﹤0.01% 2758
2017
Q3 		$274K Sell
4,065
-1,100
-21% -$79.5K ﹤0.01% 2536
2017
Q2 		$353K Buy
5,165
+5,106
+8,654% +$333K ﹤0.01% 2214
2017
Q1 		$4K Sell
59
-1,612
-96% -$104K ﹤0.01% 4331
2016
Q4 		$105K Buy
+1,671
New +$106K ﹤0.01% 2819
2016
Q3 		– Sell
-2,359
Closed -$122K – 4730
2016
Q2 		$122K Buy
2,359
+1,559
+195% +$241K ﹤0.01% 2727
2016
Q1 		$138K Buy
800
+341
+74% +$58.2K ﹤0.01% 2592
2015
Q4 		$101K Buy
+459
New +$96.3K ﹤0.01% 2969

Other funds holding LPCN

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
SC
Stempoint Capital New York $522M AUM 281.95% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
SFCM
Seven Fleet Capital Management Mountain View, California $318M AUM
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Group One Trading's LPCN Position: Q1 2026 in Review

Group One Trading reduced its Lipocine (LPCN) stake by 19% in Q1 2026, selling an estimated $261 and leaving 132 shares worth $1.05K. The position accounts for ﹤0.01% of the portfolio, ranked #7208.

Group One Trading first reported a position in LPCN in Q4 2016 and has held it in 25 quarters since. The position peaked at $98K in Q1 2018. 47 funds tracked by Wall St. Rank hold LPCN as of Q1 2026.

  • Group One Trading held 132 shares of Lipocine worth $1.05K as of Q1 2026.
  • Group One Trading sold 30 Lipocine shares in Q1 2026, an estimated $261.
  • Lipocine made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7208 holding.
  • Group One Trading first reported a position in Lipocine in Q4 2016 and has held it in 25 quarters since.
  • Group One Trading's Lipocine position peaked at $98K in Q1 2018.
  • 47 funds tracked by Wall St. Rank held Lipocine as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.